Generali Investments Management Co LLC acquired a new position in Teladoc Health, Inc. (NYSE:TDOC – Free Report) during the fourth quarter, Holdings Channel.com reports. The firm acquired 7,022 shares of the health services provider’s stock, valued at approximately $64,000.
Several other institutional investors have also recently made changes to their positions in TDOC. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Teladoc Health by 15.5% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,701,161 shares of the health services provider’s stock valued at $15,617,000 after acquiring an additional 228,004 shares during the period. Jennison Associates LLC purchased a new position in shares of Teladoc Health during the 3rd quarter valued at approximately $1,544,000. Massachusetts Financial Services Co. MA lifted its stake in shares of Teladoc Health by 477.1% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 370,093 shares of the health services provider’s stock valued at $3,397,000 after purchasing an additional 305,961 shares during the period. Geode Capital Management LLC lifted its stake in shares of Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after purchasing an additional 56,864 shares during the period. Finally, Maple Rock Capital Partners Inc. purchased a new stake in Teladoc Health during the third quarter worth $11,291,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.
Teladoc Health Stock Up 1.1 %
TDOC stock opened at $8.48 on Thursday. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average of $10.48 and a two-hundred day moving average of $9.73. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $15.68. The company has a market cap of $1.47 billion, a price-to-earnings ratio of -1.47 and a beta of 1.27.
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the stock. Oppenheimer cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. Bank of America lifted their price target on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. The Goldman Sachs Group lowered their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Piper Sandler cut their price objective on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Teladoc Health currently has a consensus rating of “Hold” and an average price target of $11.26.
Read Our Latest Stock Analysis on Teladoc Health
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
- Five stocks we like better than Teladoc Health
- How to Use Stock Screeners to Find Stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What Are Dividend Champions? How to Invest in the Champions
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is a Dividend King?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.